ACHV Achieve Life Sciences, Inc Quarterly EPS earnings growth

Brandmark of Achieve Life Sciences (ACHV)

The quarterly EPS history demonstrates the financial volatility of Achieve Life Sciences (ACHV), driven by regulatory costs. The value -118.20 shows the current metric level, reflecting a cash deficit. However, Achieve Life Sciences (ACHV) relies on partnerships with research centers to accelerate therapy. The strategy is based on establishing citizinicline as the gold standard for combating nicotine addiction and vaping.

achievelifesciences.com (ACHV) - Year-over-year net earnings per share growth for the last 12 months from 07/04/2022 to 11/10/2026

Summary analytical data breakdowns for Achieve Life Sciences (ACHV)

- market value and analyst target forecast:
Comprehensive company analysis:Achieve Life Sciences, Inc, ACHV
Flagship merchandise of Achieve Life Sciences Inc

Quarterly EPS growth measures the dynamics of net income per share, reflecting the efficiency of capital generation over a period. Investors utilize quarterly EPS fluctuations to assess business scaling rates and operational resilience. A decline in this metric signals falling profitability. For Achieve Life Sciences (ACHV), this metric is critical while awaiting NDA approval for citizinicline. The drug's success in a massive market would radically shift the profit trend.

Direct competitors

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|skyebioscience.com - Year-over-year net earnings per share growth for the last 12 months|Anebulo (ANEB) - Earnings per share growth in annualized terms for the last twelve months|Canndoc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Year-over-year earnings per share growth for the last twelve months|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)